Collegium Pharmaceutical, Inc. - Common Stock — 재무제표 (NASDAQ:COLL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 총 부채 457.81 M489.15 M979.29 M947.88 M1.43 B1.36 B 자본금 총액 186.03 M202.93 M194.84 M195.43 M228.84 M301.68 M 총 부채 및 주주자본 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 총부채 257.09 M249.99 M700.95 M667.17 M852.49 M809.33 M 순부채 82.97 M63.56 M527.26 M280.29 M595.53 M267.22 M

뉴스

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to Decline

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium Pharmaceutical Q4 실적, 수익 에상치보다 저조

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates